Glialia is a specialized medical food based on ultramicronized Palmitoylethanolamide (PEA) and Luteolin. Powered by the PEALut® formula, it is designed to manage glial cell (microglia and astroglia) activation to support cognitive health. Gluten-free & Lactose-free.
Glialia is a ready-to-use oral suspension developed to address disorders associated with chronic neuroinflammation of the central nervous system (CNS). This medical food is intended for use under medical supervision for patients at risk of neurodegenerative processes.
The formula is based on the innovative ultramicronized PEALut® composite (Palmitoylethanolamide + Luteolin in a 10:1 ratio). Thanks to co-ultramicronization technology (particle size: 0.8–6.0 microns), Glialia ensures superior bioavailability.
According to the official instructions, Glialia is recommended for conditions involving microglial and astroglial neuroinflammation:
| Component | Amount | Function |
|---|---|---|
| Ultramicronized Palmitoylethanolamide (PEA) | 700 mg | Endogenous modulator of inflammation; restores nerve tissue homeostasis. |
| Ultramicronized Luteolin | 70 mg | Flavonoid with powerful antioxidant and anti-inflammatory activity. |
| Energy value | 7.9 kcal | Low-calorie formula. |
Full ingredient list: Water, corn dextrin, stabilizers (microcrystalline cellulose, sodium carboxymethylcellulose), emulsifier (polysorbate 80), preservatives (potassium sorbate, benzoic acid), acidity regulator (citric acid).
Important: Use under medical supervision.


